Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes-Reference-Cited by-同舟云学术

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes

Published:2011-04 Issue:4 Volume:35 Page:504-507
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Alimena Giuliana,Breccia Massimo,Musto Pellegrino,Cilloni Daniela,D’Auria Fiorella,Latagliata Roberto,Sanpaolo Grazia,Gottardi Enrico,Saglio Giuseppe,Mandelli Franco

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference14 articles.

1. Myelodysplastic syndromes;Nimer;Blood,2008

2. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

3. Advancements in the molecular pathogenesis of myelodysplastic syndrome;Epling-Burnette;Curr Opin Hematol,2009

4. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions—a review;Bernasconi;Br J Haematol,2008

5. PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells;Galimberti;Leuk Res,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes;Annals of Hematology;2022-03-08

2. Crosstalk between β-catenin and WT1 signalling activity in acute myeloid leukemia;2021-11-07

3. A phase I clinical trial to study the safety of treatment with tipifarnib combined with bortezomib in patients with advanced stages of myelodysplastic syndrome and oligoblastic acute myeloid leukemia;Leukemia Research;2021-06

4. Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS;Blood Cancer Journal;2019-11

5. Deferasirox drives ROS-mediated differentiation and induces interferon-stimulated gene expression in human healthy haematopoietic stem/progenitor cells and in leukemia cells;Stem Cell Research & Therapy;2019-06-13